PRESS RELEASE published on 03/03/2026 at 07:00, 2 months 14 days ago MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation MindMaze Therapeutics provides corporate update and publishes March 2026 investor presentation, focusing on expansion in the US and Europe, organizational restructuring, and governance changes Expansion Investor Presentation Corporate Update Neurological Diseases MindMaze Therapeutics
BRIEF published on 12/23/2025 at 07:05, 4 months 25 days ago MindMaze Therapeutics : Faire progresser les stratégies de remboursement mondiales Thérapies Basées Sur L'IA Innovation Dans Le Secteur De La Santé MindMaze Thérapeutique Neuroréadaptation Numérique Stratégie De Remboursement
BRIEF published on 12/23/2025 at 07:05, 4 months 25 days ago MindMaze Therapeutics: Advancing Global Reimbursement Strategies Healthcare Innovation MindMaze Therapeutics Digital Neurorehabilitation Reimbursement Strategy AI-powered Therapies
PRESS RELEASE published on 12/23/2025 at 07:00, 4 months 25 days ago MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics MindMaze Therapeutics Holding SA outlines a global reimbursement strategy for next-generation neurotherapeutics, focusing on scalability and sustainable growth across major healthcare systems Healthcare Systems MindMaze Therapeutics Global Reimbursement Strategy Neurotherapeutics Reimbursement Durability
BRIEF published on 12/15/2025 at 07:05, 5 months 2 days ago Relief Therapeutics et NeuroX finalisent leur fusion pour former MindMaze Therapeutics SIX Swiss Exchange Fusion D'entreprises Maladies Neurologiques Traitements Numériques MindMaze Thérapeutique
BRIEF published on 12/15/2025 at 07:05, 5 months 2 days ago Relief Therapeutics and NeuroX Finalize Merger to Form MindMaze Therapeutics SIX Swiss Exchange Business Merger Neurological Diseases MindMaze Therapeutics Digital Treatments
PRESS RELEASE published on 12/15/2025 at 07:00, 5 months 2 days ago Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics Relief Therapeutics and NeuroX complete business combination forming MindMaze Therapeutics. Newly integrated entity aims to redefine neurological care with digital treatments and AI-powered solutions Business Combination Relief Therapeutics NeuroX MindMaze Therapeutics Neurological Care
BRIEF published on 11/25/2025 at 07:05, 5 months 22 days ago Relief Therapeutics et NeuroX présentent leurs perspectives financières en vue de leur fusion Marge D'EBITDA Perspectives Financières Thérapeutiques De Soulagement Fusion NeuroX Neurothérapie Numérique
BRIEF published on 11/25/2025 at 07:05, 5 months 22 days ago Relief Therapeutics and NeuroX Present Financial Outlook for Merger EBITDA Margin Financial Outlook Relief Therapeutics NeuroX Merger Digital Neurotherapeutics
PRESS RELEASE published on 11/25/2025 at 07:00, 5 months 22 days ago Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets Business Combination Financial Outlook Relief Therapeutics Press Conference NeuroX
Published on 05/16/2026 at 01:15, 1 day 18 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 19 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 20 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 3 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 23 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 1 hour ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 4 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 4 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 9 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 10 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 1 hour ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES